These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3407549)
1. Lack of involvement of leukotriene and platelet activating factor in passive cutaneous anaphylaxis in rats. Taira M; Kohno SW; Yamamura H; Ohata K Agents Actions; 1988 Jun; 24(1-2):189-95. PubMed ID: 3407549 [TBL] [Abstract][Full Text] [Related]
2. Effect of CV-3988, a specific antagonist against platelet activating factor, on homologous passive cutaneous anaphylaxis in the mouse ear. Inagaki N; Miura T; Ohira K; Nagai H; Xu QA; Koda A J Pharmacobiodyn; 1990 May; 13(5):272-7. PubMed ID: 2177106 [TBL] [Abstract][Full Text] [Related]
3. Histamine, leukotriene D4 and platelet-activating factor in guinea pig passive cutaneous anaphylaxis. Weg VB; Watson ML; Cordeiro RS; Williams TJ Eur J Pharmacol; 1991 Nov; 204(2):157-63. PubMed ID: 1687219 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of glucocorticoids on increased vascular permeability caused by passive cutaneous anaphylaxis and some chemical mediators in rats. Inagaki N; Miura T; Nagai H; Koda A Jpn J Pharmacol; 1988 Feb; 46(2):189-92. PubMed ID: 3379829 [TBL] [Abstract][Full Text] [Related]
5. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear. Inagaki N; Goto S; Yamasaki M; Nagai H; Koda A Int Arch Allergy Appl Immunol; 1986; 80(3):285-90. PubMed ID: 3087885 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats. Inagaki N; Miura T; Daikoku M; Nagai H; Koda A Pharmacology; 1989; 39(1):19-27. PubMed ID: 2479953 [TBL] [Abstract][Full Text] [Related]
7. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Hwang SB; Li CL; Lam MH; Shen TY Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239 [TBL] [Abstract][Full Text] [Related]
8. Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: comparison with cutaneous anaphylaxis. Woodward DF; Wasserman MA; Weichman BM Eur J Pharmacol; 1983 Sep; 93(1-2):9-19. PubMed ID: 6313400 [TBL] [Abstract][Full Text] [Related]
9. Leucotrienes, SRS-A and the vascular manifestations of PCA. Morley J; Page C; Paul W Agents Actions; 1981 Dec; 11(6-7):585-7. PubMed ID: 6122355 [TBL] [Abstract][Full Text] [Related]
10. Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. Detsouli A; Lefort J; Vargaftig BB Br J Pharmacol; 1985 Apr; 84(4):801-10. PubMed ID: 4005486 [TBL] [Abstract][Full Text] [Related]
11. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs. Yamamura H; Kohno S; Ohata K Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245 [TBL] [Abstract][Full Text] [Related]
12. Prolonged pulmonary hypertension caused by platelet-activating factor and leukotriene C4 in the rat lung. Davidson D; Drafta D J Appl Physiol (1985); 1992 Sep; 73(3):955-61. PubMed ID: 1400062 [TBL] [Abstract][Full Text] [Related]
13. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene. Lefort J; Rotilio D; Vargaftig BB Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375 [TBL] [Abstract][Full Text] [Related]
14. Vascular permeability increase in the mouse paw during the passive anaphylaxis reaction. Qu XF; Yamaki K; Oh-ishi S Jpn J Pharmacol; 1991 Oct; 57(2):255-7. PubMed ID: 1812304 [TBL] [Abstract][Full Text] [Related]
15. Role of leukotrienes in vascular changes in the rat mesentery and skin in anaphylaxis. Leng W; Kuo CG; Qureshi R; Jakschik BA J Immunol; 1988 Apr; 140(7):2361-8. PubMed ID: 3351303 [TBL] [Abstract][Full Text] [Related]
16. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions. Ueno A; Tokumasu T; Naraba H; Oh-ishi S Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757 [TBL] [Abstract][Full Text] [Related]
17. Leukotriene receptors in the skin of rats differ from those of mouse skin or rat stomach strip. Miura T; Inagaki N; Goto S; Yoshida K; Nagai H; Koda A Eur J Pharmacol; 1992 Oct; 221(2-3):333-42. PubMed ID: 1330627 [TBL] [Abstract][Full Text] [Related]
18. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent. Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995 [TBL] [Abstract][Full Text] [Related]
19. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism. Hatakeyama K; Yano S; Watanabe K Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120 [TBL] [Abstract][Full Text] [Related]
20. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions. Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]